LL-37, human (TFA)
CAT:
804-HY-P1222A-03
Size:
25 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
LL-37, human (TFA)
- UNSPSC Description: LL-37, human TFA is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity. LL-37, human TFA could help protect the cornea from infection and modulates wound healing[1][2][3].
- Target Antigen: Bacterial
- Type: Peptides
- Related Pathways: Anti-infection
- Applications: COVID-19-immunoregulation
- Field of Research: Infection
- Assay Protocol: https://www.medchemexpress.com/ll-37-human-tfa.html
- Purity: 99.78
- Solubility: H2O : 100 mg/mL (ultrasonic)
- Smiles: [LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES (TFA salt)]
- Molecular Weight: 4493.26 (free base)
- References & Citations: [1]Dürr UH, et al. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta. 2006 Sep;1758(9):1408-25.|[2]Huang LC, et al. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2369-80.|[3]Hou M, et al. Antimicrobial peptide LL-37 and IDR-1 ameliorate MRSA pneumonia in vivo. Cell Physiol Biochem. 2013;32(3):614-23.Int Immunopharmacol. 2024 Feb 15:129:111636.|Commun Biol. 2022 Jun 8;5(1):559.
- Shipping Conditions: Blue Ice
- Storage Conditions: -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
- Clinical Information: No Development Reported